R0L Stock Overview
Engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
J Frontier Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥18.40 |
| 52 Week High | JP¥30.70 |
| 52 Week Low | JP¥16.10 |
| Beta | 0.49 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -36.61% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -38.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| R0L | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 0.8% |
| 1Y | -36.6% | 17.4% | 9.1% |
Return vs Industry: R0L underperformed the German Healthcare industry which returned 22.6% over the past year.
Return vs Market: R0L underperformed the German Market which returned 14% over the past year.
Price Volatility
| R0L volatility | |
|---|---|
| R0L Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: R0L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine R0L's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 255 | Atsuhiro Nakamura | jfrontier.jp |
J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy.
J Frontier Co.,Ltd. Fundamentals Summary
| R0L fundamental statistics | |
|---|---|
| Market cap | €45.41m |
| Earnings (TTM) | -€10.49m |
| Revenue (TTM) | €104.28m |
0.4x
P/S Ratio-4.3x
P/E RatioIs R0L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R0L income statement (TTM) | |
|---|---|
| Revenue | JP¥17.01b |
| Cost of Revenue | JP¥9.08b |
| Gross Profit | JP¥7.93b |
| Other Expenses | JP¥9.64b |
| Earnings | -JP¥1.71b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -346.37 |
| Gross Margin | 46.62% |
| Net Profit Margin | -10.05% |
| Debt/Equity Ratio | 105.3% |
How did R0L perform over the long term?
See historical performance and comparison